News & Analysis on Clinical Trial Services & Contract Research And Development
GlaxoSmithKline (GSK) has created a Centre of Excellence for External Drug Discovery (CEEDD) that aims to provide GSK with alternative scientific and drug discovery approaches. The CEEDD also aims to exploit the full potential of GSK's R&D assets to...
Novis Pharmaceutical and Science Division (UK) is looking for three strong sales and business developers to take our award winning daily online news services to the next level.
Belgium's Printing International introduced a single-station version of its ultra high quality (UHQ) tablet printing technology into the US market via local distributor AC Compacting.
Chiral Quest has opened up a production facility near Shanghai in China, to tap into the trend by pharmaceutical companies to site manufacturing operations in the region, writes Phil Taylor.
BioProgress has appointed Richard Trevillion as chief executive, bolstering its executive management just over a month after the dosage film specialist issued a trading statement that sparked a 40 per cent slump in its UK-listed shares, which prompted...
Scientists have reported that a molecule previously thought to play a purely structural and inert role in cells may play a key role in bringing about multidrug resistance in cancer.
The US Food and Drug Administration (FDA) says it has made significant progress in the battle against counterfeit prescription drugs.
Companies that want to develop systems that comply with the US Food and Drug Administration's PAT (process analytical technology) recommendations can tap into a new modular fluid handling and measurement concept in development at a consortium of...
Evident Technologies has launched the world's first commercially available non-heavy metal quantum dot (QD) reagents that are less toxic to cells.
According to a new survey, there are currently 399 new medicines in development now to treat cancer. The survey shows that many of these medicines represent potential breakthrough cancer treatments, while others involve possible new uses for existing...
Biotechnology company, Biogen has announced the identification of a molecule that may play a key role in the repair and regeneration of the central nervous system (CNS). The finding could lead to potential pathways for treating multiple sclerosis (MS)...